Evoq Remedies share news, announcements and annual reports
BSE: 543500Commercial Services & SuppliesSmall Cap
Evoq Remedies Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2022
Last close ₹1.63₹0.00 (0.00%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹1.63.
30 Oct: open ₹1.63, high ₹1.63, low ₹1.63
52-week range of traded prices to 30 Oct 2026
₹1.35Low, 22 Sep 2026₹5.16High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4.06 Cr4,812th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.09
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 8,000
Evoq Remedies board meetings
55 filed, newest first. Page 1 of 2.
May 2026
27 May · Board meeting
Meeting on 30 May 2026: half yearly results11 May · Board meeting
Meeting on 27 May 2026: half yearly resultsNot held on this date
Oct 2025
9 Oct · Board meeting
Meeting on 10 Oct 2025: half yearly results and quarterly results
Aug 2025
26 Aug · Board meeting
21 Aug · Board meeting
Jun 2025
May 2025
17 May · Board meeting
17 May · Board meeting
2 May · Board meeting
Meeting on 6 May 2025: preferential issue of shares
Apr 2025
29 Apr · Board meeting
24 Apr · Board meeting
Meeting on 29 Apr 2025: issue of warrants and preferential issue of shares24 Apr · Board meeting
3 Apr · Board meeting
Meeting on 10 Apr 2025: audited results and half yearly results
Jan 2025
21 Jan · Board meeting
Oct 2024
Sep 2024
6 Sep · Board meeting
Aug 2024
Jun 2024
May 2024
27 May · Board meeting
21 May · Board meeting
Meeting on 27 May 2024: audited results and half yearly results
Feb 2024
Jan 2024
16 Jan · Board meeting
Meeting on 22 Jan 2024: preferential issue of shares
Nov 2023
8 Nov · Board meeting
Meeting on 10 Nov 2023: half yearly results
Oct 2023
Sep 2023
11 Sep · Board meeting
May 2023
10 May · Board meeting
Meeting on 25 May 2023: audited results and half yearly results
Nov 2022
Oct 2022
17 Oct · Board meeting
Meeting on 7 Nov 2022: rights issue of equity shares and half yearly results